Stay updated on ModuLung: Metronomic Treosulfan Clinical Trial
Sign up to get notified when there's something new on the ModuLung: Metronomic Treosulfan Clinical Trial page.

Latest updates to the ModuLung: Metronomic Treosulfan Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the Phase II NSCLC study is available, describing the comparison of treosulfan, pioglitazone, and clarithromycin with nivolumab, along with participant criteria, study locations, and measured outcomes.SummaryDifference67%

- Check13 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA general NIH banner announces a website transition and terminology update. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study details with an access-denied message.SummaryDifference20%

- Check62 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0. This reflects a routine page version update without altering the study content or data.SummaryDifference0.0%

Stay in the know with updates to ModuLung: Metronomic Treosulfan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ModuLung: Metronomic Treosulfan Clinical Trial page.